Biblio

Found 27 results
Author Keyword Title Type [ Year(Asc)]
Filters: Author is Gunnar B Kristensen  [Clear All Filters]
2011
G. J. S. Rustin, Vergote, I. B., Eisenhauer, E., Pujade-Lauraine, E., Quinn, M., Thigpen, T., du Bois, A., Kristensen, G. B., Jakobsen, A., Sagae, S., Greven, K., Parmar, M. K. B., Friedlander, M. Leonard, Cervantes, A., Vermorken, J. B., and Intergroup, G. Cancer, Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG), Int J Gynecol Cancer, vol. 21, pp. 419-23, 2011.
T. Thigpen, du Bois, A., McAlpine, J., DiSaia, P., Fujiwara, K., Hoskins, W. J., Kristensen, G. B., Mannel, R., Markman, M., Pfisterer, J., Quinn, M., Reed, N. Simon, Swart, A. Marie, Berek, J. S., Colombo, N., Freyer, G., Gallardo, D., Plante, M., Poveda, A. M., Rubinstein, L., Bacon, M., Kitchener, H. C., and Stuart, G. C. E., First-line therapy in ovarian cancer trials., Int J Gynecol Cancer, vol. 21, no. 4, pp. 756-62, 2011.
T. J. Perren, Swart, A. Marie, Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., du Bois, A., Sehouli, J., Kimmig, R., Stähle, A., Collinson, F., Essapen, S., Gourley, C., Lortholary, A., Selle, F., Mirza, M. R., Leminen, A., Plante, M., Stark, D., Qian, W., Parmar, M. K. B., and Oza, A. M., A phase 3 trial of bevacizumab in ovarian cancer., N Engl J Med, vol. 365, no. 26, p. 2496, 2011.
G. B. Kristensen, Perren, T. J., Qian, W., Pfisterer, J., Ledermann, J. A., Joly, F., Carey, M. S., Beale, P., Cervantes, A., and Oza, A. M., Result of interim analysis of overall survival in the phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer. , J Clin Oncol , vol. 29, no. suppl; abstr LBA5006, 2011.
2010
T. J. Perren, Swart, A. Marie, Pfisterer, J., Ledermann, J. A., Lortholary, A., Kristensen, G. B., Carey, M. S., Beale, P., Cervantes, A., and Oza, A. M., . ICON7: A phase III randomised Gynaecologic Cancer InterGroup trial of concurrent bevacizumab and chemotherapy followed by maintenance bevacizumab, versus chemotherapy alone in women with newly diagnosed epithelial ovarian, primary peritoneal or fallopia, Ann Oncol , vol. 21, no. Suppl 8, abstr LBA4, 2010.
I. B. Vergote, Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. Benedetti, Kenter, G. G., Casado, A., Mendiola, C., Coens, C., Verleye, L., Stuart, G. C. E., Pecorelli, S., and Reed, N. Simon, Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer., N Engl J Med, vol. 363, no. 10, pp. 943-53, 2010.
E. Pujade-Lauraine, Wagner, U., Åvall-Lundqvist, E., Gebski, V., Heywood, M., Vasey, P. A., Volgger, B., Vergote, I. B., Pignata, S., Ferrero, A., Sehouli, J., Lortholary, A., Kristensen, G. B., Jackisch, C., Joly, F., Brown, C., Le Fur, N., and du Bois, A., Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse., J Clin Oncol, vol. 28, no. 20, pp. 3323-9, 2010.
T. Högberg, Signorelli, M., de Oliveira, C. F., Fossati, R., Lissoni, A., Sorbe, B., Andersson, H., Grenman, S., Lundgren, C., Rosenberg, P., Boman, K., Tholander, B., Scambia, G., Reed, N. Simon, Cormio, G., Tognon, G., Clarke, J., Sawicki, T., Zola, P., and Kristensen, G. B., Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer–results from two randomised studies, Eur J Cancer, vol. 46, pp. 2422-31, 2010.
2005
A. du Bois, Quinn, M., Thigpen, T., Vermorken, J. B., Åvall-Lundqvist, E., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Neijt, J. P., Oza, A. M., Ozols, R., Parmar, M. K. B., Pecorelli, S., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Stuart, G. C. E., Trimble, E. L., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., and Wagner, U., 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)., Ann Oncol, vol. 16 Suppl 8, pp. viii7-viii12, 2005.
G. C. E. Stuart, Åvall-Lundqvist, E., du Bois, A., Bookman, M. A., Bowtell, D. D. L., Brady, M. F., Casado, A., Cervantes, A., Eisenhauer, E., Friedlander, M. Leonard, Fujiwara, K., Grenman, S., Guastalla, J. P., Harper, P., Högberg, T., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Oza, A. M., Ozols, R., Parmar, M. K. B., Pfisterer, J., Poveda, A. M., Provencher, D. M., Pujade-Lauraine, E., Quinn, M., Randall, M., Rochon, J., Rustin, G. J. S., Sagae, S., Stehman, F. B., Trimble, E. L., Thigpen, T., Vasey, P. A., Vergote, I. B., Verheijen, R. H. M., Vermorken, J. B., and Wagner, U., 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration., Ann Oncol, vol. 16 Suppl 8, pp. viii36-viii38, 2005.
T. Thigpen, Stuart, G. C. E., du Bois, A., Friedlander, M. Leonard, Fujiwara, K., Guastalla, J. P., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Poveda, A. M., Provencher, D. M., Stehman, F. B., Vergote, I. B., InterGroup, G. Cancer, ,, -CTG, N. C. I. C., -OVAR, A. G. O., ,, ,, ,, ,, /NCRI, M. R. C., ,, ,, ,, and , Clinical trials in ovarian carcinoma: Requirements for standard approaches and regimens, Ann Oncol, vol. 16 Suppl 8, pp. viii13-viii19, 2005.
T. Thigpen, Stuart, G. C. E., du Bois, A., Friedlander, M. Leonard, Fujiwara, K., Guastalla, J. P., Kaye, S. B., Kitchener, H. C., Kristensen, G. B., Mannel, R., Meier, W., Miller, B., Poveda, A. M., Provencher, D. M., Stehman, F. B., and Vergote, I. B., Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens., Ann Oncol, vol. 16 Suppl 8, pp. viii13-viii19, 2005.

Pages